The word ‘clinical trial’ carries weight. For many chronic migraine sufferers who have already spent years trying medication after medication, managing side effects, tracking triggers, and living around their next migraine headache attack. The idea of enrolling in a research study can feel overwhelming, even frightening. Fear of the unknown, worry about placebo groups, uncertainty about medication requirements, and anxiety about the injections themselves are all completely understandable reactions.
But those fears, while valid, are largely built on misconceptions. The PREEMPT trials, the landmark research program that led to FDA and Health Canada’s approval of therapeutic Botox for chronic migraine prevention offer a powerful case study in what ethical, patient-centered 
migraine research actually looks like. Here is the truth behind the most common myths, followed by the perspective of someone who lived it firsthand.
IGRAINE CLINICAL TRIALS
AND THE TRUTH
✗ Myth: “Clinical trials are dangerous experiments.”
✓ The PREEMPT trials followed strict FDA and international safety protocols with full informed consent at every stage. Botulinum toxin had already been FDA approved for 21 years across multiple conditions before the migraine trials began. Participants were never testing an unknown substance, they were accessing established science in a new, carefully monitored application.
✗ Myth: “I might get the placebo and receive no help for my migraines.”
✓ Even placebo participants in PREEMPT experienced meaningful migraine relief averaging 6 fewer headache days per month, likely because the structured care, regular specialist monitoring, and headache diaries provided during trial participation are themselves therapeutic. After the blind phase ended, every participant gained access to active Botox treatment. No one was abandoned.
✗ Myth: “I’ll have to stop all my migraine medications to participate.”
✓ PREEMPT participants were permitted to continue using acute rescue medications including triptans throughout the study for breakthrough migraine attacks. The trial was evaluating a preventive migraine treatment, not stripping away existing headache relief tools. Patients were fully supported at every stage.
✗ Myth: “Thirty-one injections sounds terrifying.”
✓ The PREEMPT protocol uses an ultra-fine 30-gauge needle, among the thinnest in clinical medicine. Patients consistently describe the experience as brief, mild pinching sensations. The entire appointment takes 20 to 30 minutes, with no downtime. Participants return to work, family, and daily life immediately after each session.
✗ Myth: “The Botox could spread and cause serious harm.”
✓ The FDA confirmed in its approval statement that there were no confirmed serious cases of toxin spread at the recommended migraine dose. In the PREEMPT studies, no participants developed neutralizing antibodies to Botox at study completion. The doses used in chronic migraine prevention are among the lowest of any Botox therapeutic application.
What Participating in Migraine Research Actually Felt Like
Sarah M., 41 — Marketing Director
Chronic migraine trial participant | Now in ongoing therapeutic Botox treatment
“I was having 18 to 20 migraine headache days every month. I had tried three preventive medications and none of them worked well enough. When my neurologist mentioned a clinical trial, my first reaction was fear, I imagined being a test subject with no control. But she walked me through every step, and once I understood the protocol, I felt more cared for than I ever had as a migraine patient. Someone was tracking every headache, every migraine trigger, every symptom. I felt genuinely seen. By my second treatment cycle, I was down to 7 or 8 headache days a month. I cried at my follow-up, not from pain, but from relief. Saying yes to that trial gave me my life back, and the evidence we helped build is now helping thousands of other migraine sufferers every year.”
Why Therapeutic Botox Remains the Gold Standard
for Chronic Migraine Prevent
The PREEMPT trials did not just produce an FDA and Health Canada approval, they established therapeutic Botox as the most comprehensively studied preventive migraine treatment in existence. The evidence built through those 1,384 patients and 122 clinical sites continues to be validated by long-term real-world studies including COMPEL and FORWARD, which have confirmed that Botox’s migraine-prevention benefits not only hold up over years of treatment but continue to strengthen with each successive cycle.
For chronic migraine sufferers who have struggled with the cognitive fog of topiramate, the weight gain and sedation of amitriptyline, or the rebound headache cycle of overusing triptans, therapeutic Botox offers something those medications cannot: a proven, localized, non-systemic migraine prevention treatment that works with your body rather than against it. No daily pills. No
medication-overuse risk. No cognitive side effects. Just a 30-minute appointment every 12 weeks and for many patients, the most meaningful reduction in migraine headache frequency they have ever experienced.
To find out if Therapeutic Botox is right for you, schedule a consultation with Dr. Jared Nabeta, your Migraine headache specialist in Burlington. Call (905) 639-6701 or book online at NabetaDentistry.com/appointment-request.
Get your complimentary “Consumer’s Guide To Migraine and Tension Headache Relief” HERE
Call our office to Schedule an Evaluation at (905) 639-6701 or click the link below